Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of Genomic Signatures to Predict Treatment Response in the Axillary Nodes After Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

NCT02032745 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT02032745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02032745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of Genomic Signatures to Predict Treatment Response in the Axillary Nodes After Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
July 31, 2020
Enrollment
277 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms